Indeed, these options have become available for the breast cancer patients with BRCA1 mutations in Latvia just recently which might explain a relatively high amount of contralateral breast cancer cases among the carriers of both BRCA1 founder mutations. Here, BRCA1 is linked to breast carcinoma.